LLM-driven hardware verification is generally bearish for Synopsys and Cadence, but not predictably enough in the short term to justify betting against them. A post being answered argues verification is the cleanest monetization path for the new LLM capability, with private math pure plays Harmonic and Axiom Math likely to target it, so sentiment on both should worsen. The development is broadly bullish for compute. x.com 

Synopsys and Cadence are shorts while ASIC design houses Global Unichip and Alchip are longs, because hyperscalers are taking chip IP design in-house. Synopsys design IP income fell 48% in Q1 to $66.1M, yet EDA trades near 70x earnings after losing China. Megacap seat counts are flat to down as AI makes engineers 2-3x more productive; Google TPU, AWS Trainium and other ASICs sold Cadence no new seats. Global Unichip revenue is up 60%, and Alchip, working on Trainium, is the highest-beta long. … Show more

Synopsys and Cadence can turn AI chip design into usage-based revenue, which finally makes AI's impact on EDA quantifiable. Their moat is verified tools only they have, not data. As AI agents run design and verification iterations once buried in engineers' labor costs, EDA can shift from per-seat licenses to billing for compute and tool calls, sold like Claude Code or an API. That could start a loop: AI chip design advances, AI calls EDA more, and EDA usage soars. x.com  x.com  x.com  x.com  x.com  … Show more

Arm's valuation carries an absurd premium for the architecture layer. It trades at 91.9x EV/sales, far above its historical range, as Wall Street prices it as the mandatory royalty tollbooth for every custom AI chip. EDA leaders Cadence, at 30.1x, and Synopsys, at 21.2x, trade near the low end of their historical bands, priced like mature utilities, as the market stacks almost all the scarcity premium into Arm. x.com 

As LLMs commoditize, chip programs will multiply, favoring vendors paid per attempt: CEVA, Aehr Test Systems, inTEST, PDF Solutions and GSI Technology. Stable, cost-driven inference makes hardwired custom chips worth building, and every program pays for IP, yield and test, success or not. CEVA earns per-unit IP royalties, Aehr and inTEST scale with SKU count, PDF Solutions owns cross-fab yield data, and GSI is a risky memory-wall option. Ongoing architecture churn would make this early. x.com  … Show more

Synopsys and Cadence benefit as AI shifts from general-purpose to specific-purpose models, a transition moving unusually fast and a sign this is a continuation of the buildout rather than a new cycle. Synopsys and OpenAI signed a multi-year deal to build GPT-Synopsys, a model that runs Synopsys EDA tools for tasks like timing closure and verification, with shared revenue. Synopsys also announced a multi-year, $1B+ silicon IP agreement with Amazon, showing what EDA players' IP can be used for. … Show more

VeriSilicon is China's Broadcom and should take off as custom inference ASIC orders concentrate at mature ASIC design service providers. Jalapeño's 9-month tape-out shows inference ASIC design barriers are lower than assumed, because the slow work of place-and-route, timing signoff and foundry adaptation sits with turnkey platforms. Every hyperscaler wants custom inference chips but won't build back-end teams, so pipelines at Broadcom, Marvell, MediaTek and VeriSilicon should thicken. x.com  … Show more

Cerebras' first buyable price, near a $100 billion market cap after its IPO price was raised 50% and the stock doubled at open, buys an uncertain call option on an architecture with hard trade-offs. Its wafer-scale chip gives each core only 48 KB of SRAM, 44 GB in total versus 13.5 TB of HBM3E in Nvidia's GB200 NVL72 rack, and its compiler complexity means it can never match Nvidia's software optimization. Severe memory constraints and limited I/O bandwidth are its key limits. x.com  x.com 

AI should expand Cadence's market as pressure on silicon multiplies the companies designing custom chips, and every chip design startup uses its tools. EDA has risen from 7% to 11% of semiconductor R&D, and Cadence's CEO says AI agents run far more base-tool iterations, lifting usage. Moats are deep, as fabs must certify tools over years. The risk is that its few, highly savvy customers use AI to replace parts of the workflow, and it is tied to chips designed, not to inference spend. x.com 

Synopsys's OpenAI deal and investor day have blown up the bear case that frontier AI will disrupt chip-design software. When OpenAI has dominant leverage over a partner, as with Cerebras, it extracts big equity concessions; it did not with Synopsys. KeyBanc called the investor day perfectly executed, citing much better than expected initial FY27 guidance, higher long-term EDA and IP targets, margin expansion and new AWS and OpenAI partnerships, and raised its target while reiterating Overweight. … Show more